PCM

Penserra Capital Management Portfolio holdings

AUM $7.17B
1-Year Return 49.58%
This Quarter Return
+16.8%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
AUM
$2.63B
AUM Growth
+$690M
Cap. Flow
+$459M
Cap. Flow %
17.46%
Top 10 Hldgs %
21.75%
Holding
1,064
New
264
Increased
497
Reduced
181
Closed
121

Sector Composition

1 Consumer Discretionary 35.11%
2 Technology 20.8%
3 Communication Services 14.79%
4 Industrials 4.05%
5 Financials 3.26%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SUPN icon
826
Supernus Pharmaceuticals
SUPN
$2.57B
$9K ﹤0.01%
+452
New +$9K
VNO icon
827
Vornado Realty Trust
VNO
$7.81B
$9K ﹤0.01%
272
+32
+13% +$1.06K
YRD
828
Yiren Digital
YRD
$494M
$9K ﹤0.01%
3,257
-4,201
-56% -$11.6K
NGM
829
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$9K ﹤0.01%
+588
New +$9K
ADVM icon
830
Adverum Biotechnologies
ADVM
$74.3M
$8K ﹤0.01%
+81
New +$8K
ATRA icon
831
Atara Biotherapeutics
ATRA
$85.5M
$8K ﹤0.01%
+25
New +$8K
CERS icon
832
Cerus
CERS
$249M
$8K ﹤0.01%
+1,418
New +$8K
CSTL icon
833
Castle Biosciences
CSTL
$698M
$8K ﹤0.01%
+168
New +$8K
ESPR icon
834
Esperion Therapeutics
ESPR
$506M
$8K ﹤0.01%
+236
New +$8K
GLPG icon
835
Galapagos
GLPG
$2.21B
$8K ﹤0.01%
+62
New +$8K
GOSS icon
836
Gossamer Bio
GOSS
$605M
$8K ﹤0.01%
+648
New +$8K
MYGN icon
837
Myriad Genetics
MYGN
$643M
$8K ﹤0.01%
+638
New +$8K
RGNX icon
838
Regenxbio
RGNX
$479M
$8K ﹤0.01%
+320
New +$8K
RYTM icon
839
Rhythm Pharmaceuticals
RYTM
$6.63B
$8K ﹤0.01%
+378
New +$8K
TBPH icon
840
Theravance Biopharma
TBPH
$701M
$8K ﹤0.01%
+542
New +$8K
TVTX icon
841
Travere Therapeutics
TVTX
$1.89B
$8K ﹤0.01%
+434
New +$8K
ATNX
842
DELISTED
Athenex, Inc. Common Stock
ATNX
$8K ﹤0.01%
+35
New +$8K
TBIO
843
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$8K ﹤0.01%
+634
New +$8K
ZGNX
844
DELISTED
Zogenix, Inc.
ZGNX
$8K ﹤0.01%
+474
New +$8K
ALEC icon
845
Alector
ALEC
$279M
$7K ﹤0.01%
+676
New +$7K
AMPH icon
846
Amphastar Pharmaceuticals
AMPH
$1.36B
$7K ﹤0.01%
+404
New +$7K
ARVN icon
847
Arvinas
ARVN
$583M
$7K ﹤0.01%
+336
New +$7K
ENTA icon
848
Enanta Pharmaceuticals
ENTA
$190M
$7K ﹤0.01%
+170
New +$7K
FRT icon
849
Federal Realty Investment Trust
FRT
$8.78B
$7K ﹤0.01%
102
+12
+13% +$824
INGR icon
850
Ingredion
INGR
$8.22B
$7K ﹤0.01%
102
+12
+13% +$824